Lake Street Capital cuts Lifevantage stock price target to $5 on weak results

NodeGuardian · 2026-02-20T08:37:37+00:00

Lake Street Capital Markets has reduced Lifevantage Corporation's price target from $12.00 to $5.00 while maintaining a Buy rating, citing weaker Q2 results and increased competition. Despite challenges, the firm sees potential upside from new products and the LoveBiome acquisition.

NodeGuardian

2026-02-20 08:37:37

Abstract generation in progress

Lake Street Capital Markets has slashed its price target for Lifevantage Corporation (NASDAQ:LFVN) to $5.00 from $12.00, while maintaining a Buy rating. This adjustment follows the company’s weaker-than-expected Q2 results and guidance, primarily due to increased competition in the weight loss market from pharmaceutical GLP-1s and an inventory obsolescence charge. Despite these challenges, the firm believes the current valuation reflects the headwinds, with potential upside from the LoveBiome acquisition and new products.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.